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phorylation. To obtain the structural information on inhibitor/quinone binding sites, we synthe-
sized [3H]benzophenone-asimicin ([3H]BPA), a photoafﬁnity analogue of asimicin, which belongs
to the acetogenin family known as the most potent complex I inhibitor. We found that [3H]BPA
was photo-crosslinked to ND2, ND1 and ND5 subunits, by the three dimensional separation (blue-
native/doubled SDS–PAGE) of [3H]BPA-treated bovine heart submitochondrial particles. The cross-
linking was blocked by rotenone. This is the ﬁrst ﬁnding that ND2 was photo-crosslinked with a
potent complex I inhibitor, suggesting its involvement in the inhibitor/quinone-binding.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
NADH-ubiquinone oxidoreductase (complex I) is the entry en-
zyme of the respiratory chain in both mitochondria and bacteria.
Complex I is the most elaborate iron-sulfur protein with a total
mass close to 1000 kDa, composed of 45 dissimilar protein sub-
units [1,2]. Seven subunits are encoded by mitochondrial DNA
(designated ND1-6 and 4L) and the others by nuclear DNA [1,3].
The recent crystal structure of the hydrophilic domain of complex
I from Thermus thermophilus HB-8 at 3.3 Å resolution clearly
showed that the electron transfer pathway from FMN to iron-sul-
fur cluster N2, which has the highest midpoint redox potential
and is therefore considered to be the site of electron transfer to
quinone (Q) molecules [4,5]. Although the detailed mechanism ofchemical Societies. Published by E
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kamaru-Ogiso).proton translocation coupled with Q reduction remains unsolved,
Ohnishi’s group has reported the involvement of two different
types of semiquinone species, namely, SQNf (the gate of proton
transport) [6,7] and SQNs (the converter between one-electron
and two-electron transfer) [8].
Currently, more than 60 different families of compounds are
known to inhibit complex I [9]. Many of these inhibitors are with
a clear resemblance to the structure of the natural quinones in
terms of positions of hydrogen bonding groups and hydrophobic
character. They are generally believed to bind to the site in the
membrane, where it is responsible for Q reduction and/or proton
transport. Therefore, to identify the inhibitor/Q binding site(s) in
complex I, photoafﬁnity labeling experiments with various inhibi-
tors and/or Q analogues have been conducted. Rotenone-derived
photoafﬁnity probes [10] and an acetogenin analogue, [125I](tri-
ﬂuoromethyl)-phenyldiazirinylacetogenin ([125I]TDA) labeled the
ND1 subunit [11], a photoafﬁnity analogue of pyridaben labeled
the PSST and ND1 subunits [12]. A classical carboxyl group modi-
fying reagent, [14C]N,N
0
-dicyclohexylcarbodiimide, also labeled
the ND1 subunit in a manner correlated with the inhibition of
NADH-Q reductase activity [13]. It suggests that the Q reduction
site is coupled to proton translocation. An experiment with an azi-
do-ubiquinone derivative suggested the NuoM subunit (E. coli ND4lsevier B.V. All rights reserved.
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identiﬁcation was later questioned [15]. An analogue of fenpyrox-
imate, which is another potent complex I inhibitor and a pheno-
xypyrazole acaricide, labeled the ND5 subunit [16]. A
photoafﬁnity probe of quinazoline-type inhibitor labeled 49 kDa
and ND1 subunits [17].
The question of whether Q binding sites and inhibitor binding
sites as determined by labeling studies are identical or not still re-
mains to be answered due to the difﬁculty of doing competitive
experiments with exogenous short-chain ubiquinones [18]. How-
ever, information obtained from labeling experiments are impor-
tant to understand the Q binding site(s) and/or its neighboring
site(s) in complex I. These labeling studies certainly indicate that
the inhibitor/Q binding pocket must be very large. However, this
immediately raises an important question. Is it possible that all
the subunits, namely 49 kDa, PSST, ND1 and ND5 construct a single
large inhibitor/Q binding pocket in complex I [19]? It is more likely
that more than one distinct Q binding sites exist in complex I. Thus,
to explore this possibility, we designed and synthesized benzophe-
none-asimicin (BPA) (Fig. 1). Asimicin, which belongs to a chemical
family of acetogenins [20], is one of the most potent inhibitors of
complex I [9]. We used a benzophenone photoprobe, because it of-
fers the advantage of being more stable and having a longer life-
time than other photolabeling devices such as diazo and azido
groups [21].
2. Materials and methods
2.1. Materials
Bovine heart mitochondria were kindly provided by Dr. Chang-
An Yu (Oklahoma State University, OK). Bovine heart submitochon-
drial particles (SMP) were prepared as described in Ref. [22].
NaB[3H]4 was purchased from American Radiolabeled Chemicals
(St. Louis, MO). Asimicin was chemically synthesized as described
in Ref. [23]. Anti-ND2 used here had been raised by T. Yagi.
2.2. Synthetic procedures of [3H]BPA
[3H]-labeled BPA was prepared using partially protected [3H]-
labeled 34-hydroxyasimicin according to Ref. [23]. Brieﬂy,
NaB[3H]4 (6.25 lmol, 500 mCi/18.5 GBq, 80 Ci/mmol) was added
to a solution of the corresponding aldehyde (21 mg, 24 lmol) inFig. 1. (A) Structures of asmicin, its photoafﬁnity probes, benzophenone-asimicin (BPA). (
asimicin (open circles).ethanol (0.3 ml) at 10 C. After 2 h, the solution was poured into
iced water and extracted with ethyl-acetate. The combined organic
layer was dried on anhydrous MgSO4. The resulting residue was
dissolved in CH2Cl2 (0.6 ml), 34 (4-benzoylphenyl)-propionic acid
and N,N-dimethyl-4-aminopyridine (1 mg) and then 1-ehthyl-3-
(3-dimethylaminopropyl)-carbodiimide hydrochloride (5 mg,
27 lmol) were added at 0 C. The mixture was stirred overnight
at room temperature. Then the solvent was passed through a short
bed of silica gel to give the corresponding ester (17 mg, 70% yield).
BF3Et2O was added to the ester solution in dimethylsulﬁde
(0.9 ml) at 0 C. The mixture was stirred at room temperature for
2 h. Solvents were removed, and the residue was puriﬁed by silica
gel chromatography to obtain the ﬁnal product [3H]BPA (10 mg,
73% yield). The purity was >95% based on 1H-NMR (300 MHz) anal-
ysis. The speciﬁc activity was 17.82 Ci/mmol.
2.3. Enzyme activity
The NADH oxidase activity was spectrophotometrically mea-
sured using 340 nm at 30 C and the effect of inhibitors was deter-
mined. The standard assay mixture contained 150 lM NADH,
0.25 M sucrose, 50 mM sodium phosphate (pH 7.5), 1 mM EDTA,
and SMP (10–30 lg/ml).
2.4. Photoafﬁnity labeling
SMP (0.2 mg/ml) in 50 mM sodium phosphate at pH 7.5 con-
taining 250 mM sucrose was treated with [3H]BPA (50 nM) for
10 min at room temperature. Competitive inhibitors were added
before incubation with [3H]BPA and left on ice for 10 min. Samples
were then irradiated for 10 min at 4 C under 12 W UV lamp
(365 nm) at a distance of 2.5 cm. The proteins were precipitated
(256600g for 15 min at 4 C) for analyses by electrophoresis.
For a localization analysis of labeled protein bands, the gels were
cut into 1–2.5 mm slices, individually incubated with 0.5–0.75 ml
of 30% hydrogen peroxide overnight at 75 C. Radioactivity was
measured by liquid scintillation counter as previously described
[16].
2.5. Electrophoresis
SDS–PAGE was performed according to Laemmli [24] or
Schägger [25]. Blue native (BN)–PAGE was carried out on aB) Inhibition of NADH-oxidase activity in bovine heart SMP by BPA (closed circles) or
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format [26]. The position of complex I band was conﬁrmed by
activity staining with nitroblue tetrazolium. These BN–PAGE
gels were subjected to subsequent SDS–PAGE. To isolate hydropho-
bic subunits in complex I, we performed doubled SDS–PAGE
(dSDS–PAGE) [27].
2.6. Immunoblot analyses
Protein bands in SDS gels were transferred onto 0.2 mm nitro-
cellulose membranes. Immunoblot patterns were visualized with
enhanced chemiluminescence, Supersignal kits (Pierce, Rockford,
IL).
2.7. Mass spectrometry
MALDI-TOF-MS experiments were performed on an Ultraﬂex
TOF/TOF mass spetrometer (Bruker Daltonics, Billerica, MA, USA)
according to Ref. [27].
3. Results
3.1. Photoafﬁnity labeling of SMP with [3H]JBPA
We investigated the inhibitory effect of the photoreactive ana-
logue, BPA on complex I activity in SMP. Although BPA gained a
considerable bulkiness (Fig. 1A), it remarkably retained the origi-
nal strong inhibitor potency (IC50 = 1 nM) in SMP (Fig. 1B).
Photoafﬁnity labeling of SMP with 50 nM [3H]BPA resulted in
one major and two minor labeled regions, with an apparent Mr
85 kDa, and 33 kDa and 23 kDa on a 12.5% Laemmli’s SDS gel
(Fig. S1 (a)). But, with Tricine-SDS–PAGE system, the radioactivi-
ties were detected at one major 85 kDa and one minor 50 kDa
bands on a 10% gel, and much less aggregation at the entry of
the gel was observed (Fig. S1 (b)). Labeling was time dependent,
and about 90% of labeling seemed to be completed within
10 min irradiation (data not shown). Higher concentrations
(>80 nM) signiﬁcantly increased background on the SDS gels
caused by the highly lipophilic nature of BPA, while the labeling
of 23 kDa and 33 kDa bands correlated with the inhibition of
NADH oxidase activity (data not shown). The labeling of the
85 kDa band did not clearly saturate even at 160 nM, but this band
is not a complex I component, because it is larger than the largest
subunit (75 kDa) of complex I.Fig. 2. Localization of radioactivities in SMP (A) and the effect of cold BPA on the labelin
ﬁve respiratory enzyme complexes. In (B), SMP were treated with cold BPA (2 lM) for
radioactivity of each enzyme complex without (open bars) or with UV-irradiation (solid3.2. Labeling of complex I with [3H]BPA
We examined how speciﬁc is the labeling of [3H]BPA to complex
I. We analyzed [3H]BPA-treated SMP by BN–PAGE. Without cova-
lent binding initiated by UV irradiation, [3H]BPA was still strongly
associated with complex I on a BN gel (Fig. 2A). However, we also
found a substantially high background radioactivity in other mito-
chondrial complexes isolated by BN–PAGE. Non-speciﬁc [3H]BPA
binding is likely caused by its lipophilic interaction with mem-
brane phospholipids, which account for 30% of the total mass
[28]. In fact, when each band containing complex II, III, IV and V
was excised from a BN gel and directly loaded onto a SDS gel, no
radioactivity band was detected on a SDS-gel (data not shown) be-
cause non-covalently bound BPA was removed from the protein by
SDS. The UV irradiation enhanced the binding of [3H]BPA only to
complex I by 30%, while there was no effect on other respiratory
complexes (Fig. 2A). In contrast, in the presence of cold BPA, the
non-covalent binding of [3H]BPA to complex I was signiﬁcantly
suppressed to the background levels regardless of the UV irradia-
tion (Fig. 2B). Since no radioactivity band was detected on a SDS-
gel from the band containing complex I and II excised from a BN
gel of Fig. 2B regardless of UV irradiation (data not shown), we con-
cluded that the radioactivities in Fig. 2B were all non-covalently
bound BPA via membrane lipids. The incorporation of radioactivity
into complex I was completely saturated at 80 nM (Fig. S2), and the
binding of [3H]BPA to complex I basically paralleled to the inhibi-
tion of NADH oxidase activity (Fig. S2). The small dissociation in
the relationship between the labeling and inhibition seemed to
be caused by poor efﬁciency of photoactivation of [3H]BPA inside
SMP. Since it was known that NADH increases the labeling efﬁ-
ciency for the cases such as pyridaben [12] or fenpyroximate
[16], we also tried the labeling by incubating SMP with [3H]BPA
in the presence of NADH (400 lM) for 10 min at room tempera-
ture. Then sodium pyruvate (1 mM) and L-Lactate dehydrogenase
(3 units) was added to destroy the remaining NADH before UV-
irradiation. The labeling efﬁciency and patterns did not change
by the addition of NADH.
3.3. Two- and three-dimensional separation of the [3H]BPA-labeled
complex I subunits
To identify which subunits were labeled with [3H]BPA, the band
containing complex I was excised from a BN gel and directly loaded
onto a 10% Tricine-SDS gel containing 6 M urea. As shown ing (B). 50 lg of [3H]BPA-labeled SMP was loaded onto a BN gel (4–13%) to separate
10 min on ice before incubation with [3H]BPA (80 nM). The columns represent the
bars). This is a representative data from three different sets of experiments.
Fig. 3. Identiﬁcation of the photoafﬁnity-labeled proteins in complex I. (A) 2-D gel
analyses (BN- and 10% tricine-SDS–PAGE) in the presence (a) and absence (b and c)
of 6 M urea. In (c), SMP was incubated with rotenone (10 lM) before irradiation.
The arrows indicate the major radioactivity peaks, 85 kDa, 50 kDa, and 33 kDa. (B
and C) A typical gel pattern of 3-D gel analyses (BN-, 10% tricine- with or without
6M urea-, and 16% tricine-SDS–PAGE). The gel was stained with silver. The spots 1,
2, 3, and 4 were identiﬁed as subunits ND5, ND4, ND2, and ND1 respectively.
Table 1
Radioactivity of the labeled ND subunits after 3-D separation of complex I.a
Spot on 3-D gels +6 M urea 6 M urea
ND1 107 114
ND2 131 130
ND4 47 44
ND5 245 157
The values represent the averages of three different samples. Background counts
were around 25.
a Bovine heart SMP (50 lg) labeled with [3H]BPA were ﬁrst subjected to BN–
PAGE, and followed by 2-D (dSDS-PAGE) analysis.
886 E. Nakamaru-Ogiso et al. / FEBS Letters 584 (2010) 883–888Fig. 3A(a), we detected the radioactivity peaks at 85 kDa, 33 kDa,
23 kDa, and at 50 kDa as already observed in Fig. S1. Using 6 M
urea for SDS–PAGE separation is known to have some dispersing
effect and alter SDS-binding to highly hydrophobic proteins in gels.
In fact, in the absence of 6 M urea, the radioactivity peaks around
50 kDa became much smaller (Fig. 3A(b)). Furthermore, in the
presence of rotenone, the labeling of 33 kDa band was almost
completely blocked, while the labeling of 85 kDa was only partially
decreased to 70% of the control (Fig. 3A(c)). Basically similar re-
sults were obtained with piericidin A or methyl-N-isobutyl amilo-
ride, a speciﬁc inhibitor for Na+/H+ transporters (data not shown).
Then, we applied a novel technique of dSDS–PAGE. This new meth-
od has been very effective to separate highly hydrophobic mem-
brane proteins from water soluble proteins, and it has beensuccessfully employed to analyze integral membrane proteins such
as mitochondrial respiratory chain complexes [27] or those found
in synaptic vesicles [29]. Especially, hydrophobic proteins in SMP
are readily identiﬁed by their position on the gel and do not require
identiﬁcation by sequencing or peptide ﬁngerprinting [27]. The
vertical alignment of the spots in the second dimension yields
familiar spot patterns that agree with many published subunits
compositions of puriﬁed complex I [30]. In our typical dSDS–PAGE
patterns in the presence or absence of 6 M urea (Fig. 3B and C),
highly hydrophobic subunits were found above the diagonal axis
and they were clearly separated from water-soluble hydrophobic
proteins as reported. This pattern was exactly the same as the pre-
viously published data of bovine heart mitochondria, in which each
protein spot has already been identiﬁed by MS [27,30]. By compar-
ing to the known patterns, we clearly assigned four hydrophobic
spots, ND5, ND4, ND2 and ND1 on our three-dimensional (3-D)
gels. The small spot for COX1 (complex IV) and the faint spot for
Cyt.b (complex III) were also observed (Fig. 3B and C). To conﬁrm
our spot assignment, we also carried out MALDI-TOF-MS analyses.
We succeeded in identifying two peptides, 522FSTLLGYFPTDMHR535
and 426IIFFALLGQPR436 from the ND5 spot on our gels. We also
tried to conﬁrm ND1 and ND2 spots and used the corresponding
spots from ﬁve 3-D gels together for MS analysis, but we failed
to detect any peptides. The ND2 spot was conﬁrmed by Western
blot (Fig. S3). We measured the radioactivity of these ND spots
on the 3-D gels (Table 1). The size of the gels (18  14 cm) used
in Fig. 3B and C was large enough to separate ND1 and ND2 spots.
These small spots were obtained with a puncher made of a stain-
less tube. Consistent with two-dimensional (2-D) patterns
(Fig. 3A(a) and (b)), twofold higher radioactivity for the ND5 spot
was detected in the presence of 6 M urea (Table 1). In contrast,
6 M urea did not affect the radioactivities of ND1, ND2, and ND4
spots. As expected from the molecular size (Figs. 1B and 3A), we ﬁ-
nally identiﬁed that the radioactivity peaks at 50 kDa and 33 kDa
are corresponding to the spots of ND5, and ND1& ND2, respec-
tively. The radioactivity of COX I was 27 at the background level.
The radioactivities of well-isolated hydrophilic spots of 51 kDa
and 49 kDa were 35 cpm, close to the background level. When
ND1 and ND2 bands were separated on a one-dimensional (1-D)
10% SDS, we found two but fused radioactivity peaks around 30
and 33 kDa, which were reacted with speciﬁc antibodies against
ND1 and ND2 respectively with no overlapping (data not shown).
Taken together, it was concluded that ND2 was labeled as well as
ND1.
We detected high radioactivities (400 cpm) for the 85 kDa
spot. However, we concluded that the 85 kDa protein does not be-
long to complex I by the following reasons: (i) this 85 kDa spot was
very faint: (ii) no subunit larger than 75 kDa exists in complex I;
(iii) it did not react to any complex I subunit antibodies against
ND1, ND2, ND5, 51 kDa, 49 kDa, and PSST. In fact, although more
detailed study must be done, we recently found that the 85 kDa
could be long-chain 3-hydroxyacyl-CoA dehydrogenase, which is
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reduces NAD to NADH.
4. Discussion
In the present study, we demonstrated that [3H]BPA was cova-
lently incorporated into ND2, ND1 and ND5 subunits. We also ob-
served that the labeling was blocked by rotenone. This is the ﬁrst
report that ND2 was photoafﬁnity-labeled with a complex I inhib-
itor, and that this subunit is involved in the inhibitor/Q binding
sites. Unfortunately, we could not identify labeled amino acid res-
idue(s) due to a low labeling efﬁciency of [3H]BPA. This is probably
caused by the conformational ﬂexibility of benzophenone [31]. In
general, labeling experiments of complex I have been extremely
challenging for the last two decades. Only recently, Miyoshi’s
group has succeeded in locating the [125I]TDA-labeled region with-
in the 4th and 5th transmembrane helices of the ND1 subunit [11].
Using photoreactive azidoquinazoline, another cross-linked do-
main was identiﬁed in the membrane interface region, at a sub-
subunit level (within 23 amino acid polypeptide) in the 49 kDa
subunit [17].
A difference between our results and those by Miyoshi’s group,
which also used acetogenin derivatives, is attributed to the differ-
ent locations of photo-afﬁnity groups between [3H]BPA and
[125I]TDA. In other words, the cytotoxic c-lactone ring was replaced
with the photo-afﬁnity aryldiazirine group in [125I]TDA, while the
photo-afﬁnity benzophenone group was attached to the opposite
end of the alkyl chain end of asimicin in [3H]BPA (Fig. 1A). Accord-
ing to the detailed study on how acetogenins interact with the
membrane bilayers by 1H NMR spectroscopy, two tetrahydrofuran
rings act as a hydrophilic anchor in the center of lipid bilayers and
the c-lactone ring and the other end are stretched out into the
membrane in U-shaped conformations [32]. Thus the [3H]BPA-la-
beled site could be far from the primary inhibitor/Q-binding site la-
beled with [125I]TDA. Amarneh et al. previously reported that
mutants K158C and H224K in the NuoN subunit (homologous to
ND2) of E. coli complex I showed enhanced inhibition by decyl-
ubiquinone (DB) along with decreased deamino-NADH oxidase
and proton pumping activities. These ﬁndings indicate that NuoN
interacts with quinones [33]. It is interesting to note that these res-
idues are facing the cytoplasm surface and located very close or in
the predicted Q motif (LxxxHxxT) [34].
Two distinct SQ signals in complex I were detected in bovine
heart SMP by EPR: fast-relaxing uncoupler sensitive SQNf and
slow-relaxing uncoupler insensitive SQNs species. Based on their
spin-spin interaction analyses, the distance between SQNf and clus-
ter N2 was calculated as 12 Å [6], while SQNs is >30 Å away from
cluster N2 [35]. Both SQ species showed the same IC50 to piericidinA
while SQNs showed much lower sensitivity to rotenone than that to
SQNf [35]. Thus, it has been suggested that these two quinone spe-
cies have different functions and occupy different locations [35].
Based on a relatively high stability constant (Kstability) of the SQNs,
its function was suggested to be a converter between n = 1 (QNf)
and n = 2 (Q pool) electron transfer processes [8]. These previous
ﬁndings and our current data strongly suggest that ND2 is involved
in the secondary Q-binding site where the SQNs signals arise.
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